Whilst reduced-rely MBL not often progresses to CLL, high-count MBL progresses to CLL necessitating therapy at a amount of one% to two% per year. Large-rely MBL is distinguished from Rai 0 CLL dependant on whether the B-cell count is over or under five × 109/L. While people today with both hig